lisocabtagene maraleucel,ibrutinib,venetoclax
BMS,Roche,Abbvie
['liso-cel', 'cll', 'pivotal trial']
dr tanya siddiqi (aku class of 2000), not on twitter, led this pivotal trial showing impressive outcomes of liso-cel (cd19+ car-t) in refractory cll pts. practice-changing results concurrently published in (if 203) &amp; presented at #asco23! 
Lifelong 🏀 | Dad of a future @wnba #mvp | Cancer | #BMT #CART | infections | Views own | No COI | President, Milwaukee Medical Society